Treatment with recombinant human macrophage colony-stimulating factor resorbs blood clot and restores osteoclastogenesis in heterotopic bone induced by partially purified native bone morphogenetic protein in osteopetrotic (op/op) mice

Journal of Orthopaedic Research

Volumn 15, Issue 3, 1997, Pages 456-462

  Miyazawa, K ^a   Urist, M R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORPTION; BLOOD; CARTILAGE; CELLS; LIVING SYSTEMS STUDIES; MUSCLE; PROTEINS;

MACROPHAGE COLONY STIMULATING FACTORS; OSTEOCLASTOGENESIS;

BONE;

4 CARBOXYGLUTAMIC ACID; ACID PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; OSTEONECTIN; RECOMBINANT COLONY STIMULATING FACTOR 1; TARTARIC ACID;

ALBERS SCHOENBERG DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT LYSIS; BONE MARROW; BONE MATRIX; BONE REMODELING; CARTILAGE; CONTROLLED STUDY; CORTICAL BONE; FEMALE; HEMATOPOIESIS; HETEROTOPIC OSSIFICATION; IMPLANT; MALE; METAPHYSIS; MOUSE; MYELOPOIESIS; NONHUMAN; OSTEOCLAST; OSTEOID; OSTEOLYSIS; PRIORITY JOURNAL;

EID: 0031148473     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100150320     Document Type: Article

References (23)

1. 1 Begg SK, Radley JM, Pollard JW, Chisholm OT, Stanley ER, Bertoncello I: Delayed hematopoietic development in osteopetrotic (op/op) mice. J Exp Med 177: 237–242, 1993
2. 2 Burstone MS: Diazonium salts and azo‐coupling. In: Enzyme Histochemistry, and its Application in the Study of Neoplasms, pp 88–113. Ed by MS Burstone. New York, Academic Press, 1962
3. 3 Felix R, Cecchini MG, Fleisch H: Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 127: 2592–2594, 1990
4. 4 Felix R, Cecchini MG, Hofstetter W, Elford PR, Stutzer A, Fleisch H: Impairment of macrophage colony‐stimulation factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Miner Res 5: 781–789, 1990
5. 5 Halenbeck R, Kawasaki E, Wrin J, Koths K: Renaturation and purification of biologically active recombinant human macrophage colony‐stimulating factor expressed in E. coil. Biotechnology 7: 710–714, 1989
6. 6 Janckila AJ, Li CY, Lam KW, Yam LT: The cytochemistry of the tartrate‐resistant acid phosphatase: technical considerations. Am J Clin Pathol 70: 45–55, 1978
7. 7 Kawai T, Urist MR: Quantitative computation of induced heterotopic bone formation by an image analysis system. Clin Orthop 233: 262–267, 1988
8. 8 Kawamura M, Iwata H, Sato K, Miura T: Chondroosteogenetic response to crude bone matrix proteins bound to hydroxyapatite. Clin Orthop 217: 281–292, 1987
9. 9 Kodama H, Yamasaki A, Nose M, Niida S, Ohgame Y, Abe M, Kumegawa M, Suda T: Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony‐stimulating factor, J Exp Med 173: 269–272, 1991
10. 10 Kodama H, Yamasaki A, Abe M, Niida S, Hakeda Y, Kawashima H: Transient recruitment of osteoclasts and expression of their function in osteopetrotic (op/op) mice by a single injection of macrophage colony‐stimulating factor. J Bone Miner Res 8: 45–50, 1993
11. 11 Labat ML, Milhaud G: Osteopetrosis and the immune deficiency syndrome. J Bone Miner Res 4: 131–212, 1986
12. 12 Marks SC Jr, Lane PW: Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J Hered 67: 11–18, 1976
13. 13 Marks SC Jr: Morphological evidence of reduced bone resorption in osteopetrotic (op) mice. Am J Anat 163: 157–167, 1982
14. 14 Marks SC Jr: Osteoclast biology: lessons from mammalian mutations. Am J Med Genet 34: 43–54. 1989
15. 15 Miyazawa K, Kawai T, Urist MR: Bone morphogenetic proteininduced heterotopic bone in osteopetrosis. Clin Orthop 324: 259–268, 1996
16. 16 Niida S, Amizuka N, Hara F, Ozawa H, Kodama H: Expression of Mac‐2 antigen in the preosteoclast and osteoclast identified in the op/op mouse injected with macrophage colony‐stimulating factor. J Bone Miner Res 9: 873–881, 1994
17. 17 Urist MR, Budy AM, McLean FC: Endosteal‐bone formation in estrogen‐treated mice. J Bone Joint Surg [Am] 32: 143–162, 1950
18. 18 Urist MR: Bone: formation by autoinduction. Science 150: 893–899, 1965
19. 19 Urist MR, Huo YK, Brownell AG, Hohl WM, Buyske J, Lietze A, Tempsl P, Hunkapillar M, DeLange RJ: Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc Natl Acad Sci U S A 81: 371–375, 1984
20. 20 Urist MR, Chang JJ, Lietze A, Huo YK, Brownwell AG, DeLange RJ: Methods of preparation and bioassay of bone morphogenetic protein and polypeptide fragments. In: Methods in Enzymology, vol 146, pp 294–312. Ed by D Barnes and DA Sirbasku. Orlando, Academic Press, 1987
21. 21 Wiktor‐Jedrzejczak WW, Ahmed A, Szczylik C, Skelly RR: Hematological characterization of congenital osteopetrosis in op/op mouse:, possible mechanism for abnormal macrophage differentiation. J Exp Med 156: 1516–1527, 1982
22. 22 Wiktor‐Jedrzejczak W, Bartocci A, Ferrante AW Jr, Ahmed Ansari A, Sell KW, Pollard JW, Stanley ER: Total absence of colony‐stimulating factor 1 in the macrophage‐deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A 87: 4828–4832, 1990
23. 23 Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S: The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442–444, 1990